SERUM LEVELS OF FAS/APO-1 AND FAS LIGAND (FASL) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
Panafidina, T. A. [1 ]
Sokhova, M. A. [1 ]
Popkova, T. V. [1 ]
Cherkasova, M. A. [1 ]
Novikov, A. A. [1 ]
Aleksandrova, E. N. [1 ]
Nasonov, E. L. [1 ]
机构：
[1] Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4053
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0516
引用
收藏
页码：1082 / 1082
页数：1
相关论文
共 50 条
  • [41] Fas (CD95, Apo-1) ligand gene transfer
    Lamhamedi-Cherradi, SE
    Chen, YH
    JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (01) : 24 - 29
  • [42] The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations
    Vaishnaw, AK
    Toubi, E
    Ohsako, S
    Drappa, J
    Buys, S
    Estrada, J
    Sitarz, A
    Zemel, L
    Chu, JL
    Elkon, KB
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : 1833 - 1842
  • [43] Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus
    Al-Maini, MH
    Mountz, JD
    Al-Mohri, HA
    El-Ageb, EM
    Al-Riyami, BM
    Svenson, KLG
    Zhou, T
    Richens, ER
    LUPUS, 2000, 9 (02) : 132 - 139
  • [44] Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack
    O'Connell, J
    Bennett, MW
    O'Sullivan, GC
    Collins, JK
    Shanahan, F
    DISEASES OF THE ESOPHAGUS, 1999, 12 (02): : 83 - 89
  • [45] Serum soluble Fas/APO-1 is increased in patients with primary Sjogren's syndrome
    Fujihara, T
    Takeuchi, T
    Tsubota, K
    Kayagaki, N
    Yagita, H
    Okumura, K
    Abe, T
    CLINICAL RHEUMATOLOGY, 1998, 17 (06) : 496 - 499
  • [46] Elevated levels of soluble Fas in systemic lupus erythematosus: Comment
    Okubo, M
    Ishida, H
    Kasukawa, R
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1612 - 1613
  • [47] Elevated levels of soluble Fas in systemic lupus erythematosus: Reply
    Elkon, KB
    Krammer, PH
    Lynch, DH
    Goel, N
    Seldin, MF
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1613 - 1614
  • [48] Serum levels of soluble Fas/APO-1 receptor in human retroviral infection and associated diseases
    Kamihira, S
    Yamada, Y
    Hiragata, Y
    Yamaguchi, T
    Izumikawa, K
    Matsuo, Y
    Sugahara, K
    Tsuruta, K
    Atogami, S
    Tsukasaki, K
    Maeda, T
    Tomonaga, M
    INTERNAL MEDICINE, 1997, 36 (03) : 166 - 170
  • [49] Fas/Apo-1 and oxidative stress in ageing
    Kim, Y
    Lee, N
    Won, D
    Suh, J
    Song, K
    CLINICAL CHEMISTRY, 2005, 51 : A73 - A73
  • [50] Serum levels of Fas/Apo-1 and bcl-2 in children with HIV-1 infection
    Torre, D
    Zeroli, C
    Speranza, F
    Martegani, R
    Fiori, G
    Airoldi, M
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1998, 30 (06) : 565 - 568
12345